Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558843 · ClinicalTrials.gov registry record
Sodium Management in Acute Neurological Injury
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 400
- Enrollment target
NCT01558843: Completed study, sponsored by Washington University School of Medicine.
NCT01558843 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01558843 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
This multicenter, observational, study will enroll severe neurologically injured patients both prospectively and retrospectively. The aims are to identify the percent of neurocritical care patients with sodium levels ≤ 135 mEq/L, describe treatment strategies employed, determine the correlation of clinical factors (i.e. GCS, ICP) with serum sodium concentrations in patients prior to sodium altering therapy, and evaluate outcomes through evaluation of length of stay, discharge disposition, and modified Rankin score (mRS).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2012-02-01 |
| Est. Completion | 2016-10-01 |
What the finished NCT01558843 record still lists
NCT01558843 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01558843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01558843 about?
NCT01558843 is a clinical study titled "Sodium Management in Acute Neurological Injury". This multicenter, observational, study will enroll severe neurologically injured patients both prospectively and retrospectively. The aims are to identify the percent of neurocritical care patients with sodium levels ≤ 135 mEq/L, describe treatment strategies employed, determine the correlation of c...
What is the current status of trial NCT01558843?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2012-02-01. Estimated completion is 2016-10-01.
Who is sponsoring clinical trial NCT01558843?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI